University of British Columbia
Vancouver, British Columbia, V6T 1Z3, Canada
NCT Number: NCT01932281
The purpose of this study is to examine whether supplementation with SierraSil can improve anaerobic power and reduce muscle fatigue in a group of well-trained athletes.
A secondary purpose is to examine the effect of SierraSil on the severity of delayed onset muscle soreness.
Looking for future studies?
Notify Me19 year–35 year
Male
Interventional
Not applicable
Vancouver, British Columbia, V6T 1Z3, Canada
This is a double blind, crossover, pilot study that will examine the effect of SierraSil supplementation on the determinants of human performance. Anaerobic capacity, muscle fatigue, the severity of delayed onset muscle soreness (DOMS) and markers of inflammation will be measured before and after 3 weeks of supplementation with SierraSil or placebo. There will be a 3 week washout period prior to the crossover to ensure SierraSil supplementation has no residual effect.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SierraSil is a natural, mineral supplement currently used to improve joint health and function.
Sugar pill manufactured to mimic SierraSil 667 mg capsule
Time frame: change from baseline at 3 weeks
University of British Columbia
Other
SierraSil as an Ergogenic Aid to Performance in Athletes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06061315
Body Composition, Lean Body Mass
Odense, Denmark
View Trial DetailsNCT07027397
Aging, Cognitive Function
Toledo, Spain
View Trial DetailsNCT07118423
Behavior, Cognitive Abilities
Zaragoza, Spain
View Trial DetailsNCT06363669
Behavior, Motor Activity
Krakow, Poland
View Trial Details